170 related articles for article (PubMed ID: 6576910)
1. In vitro drug sensitivity studies of CFUc in chronic myelocytic leukemia: I. Suicide indices and busulfan sensitivity determinations during the chronic phase.
Preisler HD; Kirshner J
Exp Hematol; 1983 Aug; 11(7):618-25. PubMed ID: 6576910
[TBL] [Abstract][Full Text] [Related]
2. [The determination of myeloid-committed stem cells in systemic disorders of myelopoiesis: implications for physiopathology, diagnosis and prognosis].
Hinterberger W
Acta Med Austriaca Suppl; 1981; 21():1-20. PubMed ID: 6949436
[TBL] [Abstract][Full Text] [Related]
3. In vitro busulfan sensitivity of granulocyte-macrophage and erythroid progenitor cells in patients with chronic myelogenous leukemia.
Kubota K; Preisler HD; Costanzo C; Miura Y
Cancer Res; 1983 Dec; 43(12 Pt 1):6090-3. PubMed ID: 6580066
[TBL] [Abstract][Full Text] [Related]
4. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
Betticher DC; Huxol H; Müller R; Speck B; Nissen C
Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
[TBL] [Abstract][Full Text] [Related]
5. In vitro drug sensitivity studies of colony-forming units in culture in chronic myelocytic leukemia: lack of specificity between chronic-phase patients and normal donors.
Kirshner J; Preisler HD
Cancer Res; 1983 Dec; 43(12 Pt 1):6094-5. PubMed ID: 6580067
[TBL] [Abstract][Full Text] [Related]
6. Lack of relationship between in vitro cell measurements and response to busulfan in chronic myelocytic leukemia.
Kirshner J; Preisler HD; Raza A
Am J Hematol; 1985 Feb; 18(2):191-200. PubMed ID: 3855599
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of myeloid progenitor cells in healthy subjects and patients with chronic myeloid leukemia to chemotherapeutic agents.
Spiro TE; Mattelaer MA; Efira A; Stryckmans P
J Natl Cancer Inst; 1981 Jun; 66(6):1053-9. PubMed ID: 6941040
[TBL] [Abstract][Full Text] [Related]
8. [Study of colony forming cells and aggregates (CFCA) in vitro in blood and bone marrow of patients with chronic myeloid leukemia: simplified bovine serum albumin gradient centrifugation].
Berthier R; Douady F; Marcille G; Sotto JJ; Schaerer R; Hollard D
Nouv Rev Fr Hematol; 1975; 15(3):365-74. PubMed ID: 128737
[TBL] [Abstract][Full Text] [Related]
9. Circulating colony-forming cells in different stages of chronic myelocytic leukemia.
Leong SS; Sokal JE; Gomez GA; Horoszewicz JS
Cancer Res; 1979 Jul; 39(7 Pt 1):2704-10. PubMed ID: 286638
[TBL] [Abstract][Full Text] [Related]
10. [Characteristics of clonal evolution in patients with myelocytic leukemia].
Petukhov VI; Grasmane DV; Bondare DK; Baravika IIa; Medne IT
Ter Arkh; 1984; 56(6):53-8. PubMed ID: 6591505
[TBL] [Abstract][Full Text] [Related]
11. Myeloid colony-forming cell kinetics in man.
Koeffler HP; Gale RP; Golde DW
Exp Hematol; 1980 Mar; 8(3):271-7. PubMed ID: 7007065
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapeutic sensitivity of normal and leukemic hematopoietic progenitor cells to N-[4-(9-acridinylamino)-3-methoxyphenyl]-methanesulfonamide, a new anticancer agent.
Spiro TE; Socquet M; Delforge A; Stryckmans P
J Natl Cancer Inst; 1981 Apr; 66(4):615-8. PubMed ID: 6939909
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow and peripheral blood hematopoietic reserve in patients with B-cell chronic lymphocytic leukemia.
Pejsa V; Kusec R; Petrovecki M; Jaksic O; Jaksic B; Boranic M
Haematologica; 2003 Dec; 88(12):1429-31. PubMed ID: 14688001
[No Abstract] [Full Text] [Related]
14. Density profiles and purification of chronic myeloid leukemia cells forming colonies in the PHA-leukocyte feeder assay.
Swart K; Hagemeijer A; Löwenberg B
Exp Hematol; 1981 Jul; 9(6):588-94. PubMed ID: 6943037
[TBL] [Abstract][Full Text] [Related]
15. Prediction of response to chemotherapy in acute leukemia by in vitro drug sensitivity testing on leukemic stem cells.
Gustavsson A; Olofsson T
Cancer Res; 1984 Oct; 44(10):4648-52. PubMed ID: 6590116
[TBL] [Abstract][Full Text] [Related]
16. In vitro culture studies of blood and marrow cells in chronic myeloid leukemia at different phases of the disease.
Shih LY; Chiu WF; Dunn P; Liaw SJ
Blut; 1988 Sep; 57(3):125-30. PubMed ID: 3166388
[TBL] [Abstract][Full Text] [Related]
17. In vitro granulopoiesis in oligoblastic leukaemia: prognostic value, characterization and serial cloning of bone marrow colony and cluster forming cells in agar culture.
Berthier R; Douady F; Metral J; Newton I; Schweitzer A; Hollard D
Biomedicine; 1979 Dec; 30(6):305-11. PubMed ID: 526532
[TBL] [Abstract][Full Text] [Related]
18. The myeloid progenitor cell: a parallel study of subpopulations in human marrow and peripheral blood.
Verma DS; Spitzer G; Zander AR; Fisher R; McCredie KB; Dicke KA
Exp Hematol; 1980 Jan; 8(1):32-43. PubMed ID: 6967823
[TBL] [Abstract][Full Text] [Related]
19. Severe functional alterations in vitro in CD34(+) cell subpopulations from patients with chronic myeloid leukemia.
Chávez-González A; Rosas-Cabral A; Vela-Ojeda J; González JC; Mayani H
Leuk Res; 2004 Jun; 28(6):639-47. PubMed ID: 15120942
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy of chronic myelocytic leukemia.
Galton DA
Semin Hematol; 1969 Oct; 6(4):323-43. PubMed ID: 4900650
[No Abstract] [Full Text] [Related]
[Next] [New Search]
